An assessment of coverage and adverse events following country-wide triple-therapy mass drug administration for lymphatic filariasis elimination, Samoa 2018

Gabriela A. Willis, Helen Mayfield, Therese Kearns, Take Naseri, Robert Thomsen, Katherine Gass, Sarah Sheridan, Patricia M. Graves, Colleen L. Lau
doi: https://doi.org/10.1101/2020.04.21.20072363

Article usage

Article usage: April 2020 to January 2025

AbstractFullPdf
Apr 2020175026
May 2020103045
Jun 202047026
Jul 202035022
Aug 202045021
Sep 202039037
Oct 202026015
Nov 20204609
Dec 202014026
Jan 20212917
Feb 20214015
Mar 20214515
Apr 20215975
May 20215539
Jun 20214716
Jul 20211779
Aug 2021321121
Sep 20211437
Oct 20211505
Nov 20211106
Dec 20211344
Jan 20221494
Feb 20221637
Mar 20221999
Apr 20221301
May 202218813
Jun 20221554
Jul 20221544
Aug 202213101
Sep 20222418
Oct 20221963
Nov 2022815
Dec 20221135
Jan 2023844
Feb 20231539
Mar 20231032
Apr 20231467
May 2023716
Jun 2023771
Jul 2023422
Aug 202316144
Sep 2023963
Oct 20231052
Nov 20231165
Dec 20231242
Jan 2024722
Feb 2024843
Mar 2024314
Apr 202411811
May 2024847
Jun 202410210
Jul 2024131024
Aug 2024527
Sep 202412711
Oct 20248190
Nov 20246117
Dec 20249189
Jan 20251110
Back to top
Posted April 24, 2020.
Download PDF

Supplementary Material

Data/Code
Email
An assessment of coverage and adverse events following country-wide triple-therapy mass drug administration for lymphatic filariasis elimination, Samoa 2018
Gabriela A. Willis, Helen Mayfield, Therese Kearns, Take Naseri, Robert Thomsen, Katherine Gass, Sarah Sheridan, Patricia M. Graves, Colleen L. Lau
medRxiv 2020.04.21.20072363; doi: https://doi.org/10.1101/2020.04.21.20072363
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area